Unknown

Dataset Information

0

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.


ABSTRACT: Resolution of inflammation is a finely regulated process mediated by specialized proresolving lipid mediators (SPMs), including docosahexaenoic acid (DHA)-derived resolvins and maresins. The immunomodulatory role of SPMs in adaptive immune cells is of interest. We report that D-series resolvins (resolvin D1 and resolvin D2) and maresin 1 modulate adaptive immune responses in human peripheral blood lymphocytes. These lipid mediators reduce cytokine production by activated CD8(+) T cells and CD4(+) T helper 1 (TH1) and TH17 cells but do not modulate T cell inhibitory receptors or abrogate their capacity to proliferate. Moreover, these SPMs prevented naïve CD4(+) T cell differentiation into TH1 and TH17 by down-regulating their signature transcription factors, T-bet and Rorc, in a mechanism mediated by the GPR32 and ALX/FPR2 receptors; they concomitantly enhanced de novo generation and function of Foxp3(+) regulatory T (Treg) cells via the GPR32 receptor. These results were also supported in vivo in a mouse deficient for DHA synthesis (Elovl2(-/-)) that showed an increase in TH1/TH17 cells and a decrease in Treg cells compared to wild-type mice. Additionally, either DHA supplementation in Elovl2(-/-) mice or in vivo administration of resolvin D1 significantly reduced cytokine production upon specific stimulation of T cells. These findings demonstrate actions of specific SPMs on adaptive immunity and provide a new avenue for SPM-based approaches to modulate chronic inflammation.

SUBMITTER: Chiurchiu V 

PROVIDER: S-EPMC5149396 | biostudies-other | 2016 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.

Chiurchiù Valerio V   Leuti Alessandro A   Dalli Jesmond J   Jacobsson Anders A   Battistini Luca L   Maccarrone Mauro M   Serhan Charles N CN  

Science translational medicine 20160801 353


Resolution of inflammation is a finely regulated process mediated by specialized proresolving lipid mediators (SPMs), including docosahexaenoic acid (DHA)-derived resolvins and maresins. The immunomodulatory role of SPMs in adaptive immune cells is of interest. We report that D-series resolvins (resolvin D1 and resolvin D2) and maresin 1 modulate adaptive immune responses in human peripheral blood lymphocytes. These lipid mediators reduce cytokine production by activated CD8(+) T cells and CD4(+  ...[more]

Similar Datasets

| S-EPMC4285693 | biostudies-literature
| S-EPMC7313724 | biostudies-literature
| S-EPMC4447226 | biostudies-literature
| S-EPMC7348143 | biostudies-literature
| S-EPMC2824371 | biostudies-literature
| S-EPMC5124518 | biostudies-literature
| S-EPMC4855303 | biostudies-literature
| S-EPMC3424332 | biostudies-literature
| S-EPMC3349829 | biostudies-other
| S-EPMC8250053 | biostudies-literature